EXCLUSIVE LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF ARIZONA AND PROLX PHARMACEUTICALS CORPORATIONExclusive License Agreement • April 2nd, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • Arizona
Effective as of 29 day of July, 2004 ("Effective Date"), the Arizona Board of Regents on behalf of the University of Arizona, having its principal offices in Tucson, Arizona 85721 (the "LICENSOR"), and PROLX PHARMACEUTICALS CORPORATION, having a principal place of business at 221 E. Sixth Street, Tucson, Arizona 85705 ("LICENSEE"), agree as follows:
SCHEDULE 1 PLAN OF ARRANGEMENT UNDER SECTION 192 OF THE CANADA BUSINESS CORPORATIONS ACTBiomira Inc • December 12th, 2007 • Biological products, (no disgnostic substances)
EXCLUSIVE PATENT LICENSE AGREEMENT BETWEEN THE UNIVERSITY OF ARIZONA AND PROLX PHARMACEUTICALS CORPORATIONExclusive Patent License Agreement • April 2nd, 2007 • Biomira Inc • Biological products, (no disgnostic substances)
Effective as of the date of the last signature to this Agreement, the Arizona Board of Regents on behalf of the University of Arizona, having its principal offices in Tucson, Arizona 85721 (the "LICENSOR"), and PROLX PHARMACEUTICALS CORPORATION, having a principal place of business at 221 E. 6th St. Tucson, AZ 85705 ("LICENSEE"), agree as follows:
AMENDED AND RESTATED COLLABORATION AGREEMENT (2006)Collaboration Agreement • August 17th, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • England
This amended and restated agreement is between Biomira B.V. (formerly Biomira Europe B.V.), a Netherlands corporation with offices located at Amsterdam, The Netherlands ("BIOMIRA"), and Merck KGaA, a German corporation with offices located at Darmstadt, Germany ("MERCK") and is effective as of March 1, 2006.
EXHIBIT INDEXBiomira Inc • November 8th, 2007 • Biological products, (no disgnostic substances)
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG BIOMIRA INC., PROLX PHARMACEUTICALS CORPORATION, D. LYNN KIRKPATRICK AND GARTH POWIS AND WITH RESPECT TO ARTICLES VI AND VII ONLY, GARTH POWIS AS STOCKHOLDER REPRESENTATIVE Dated as of October 30, 2006Agreement and Plan of Reorganization • November 1st, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • Delaware
THIS AGREEMENT AND PLAN OF REORGANIZATION (the "Agreement") is made and entered into as of October 30, 2006 by and among Biomira Inc. a Canadian corporation ("Parent"), Biomira Acquisition Corporation, a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), ProlX Pharmaceuticals Corporation, a Delaware corporation (the "Company"), D. Lynn Kirkpatrick and Garth Powis (together, the "Principal Stockholders"), and with respect to Articles VI and VII hereof, Garth Powis as Stockholder Representative (the "Stockholder Representative").
AGREEMENT AND PLAN OF REORGANIZATION BY AND AMONG BIOMIRA INC., PROLX PHARMACEUTICALS CORPORATION, D. LYNN KIRKPATRICK AND GARTH POWIS AND WITH RESPECT TO ARTICLES VI AND VII ONLY, GARTH POWIS AS STOCKHOLDER REPRESENTATIVE Dated as of October 30, 2006Security Agreement • October 4th, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • Delaware
ARRANGEMENT AGREEMENTArrangement Agreement • September 14th, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • Alberta
AMENDED AND RESTATED SUPPLY AGREEMENT (2006)Quality Agreement • August 17th, 2007 • Biomira Inc • Biological products, (no disgnostic substances) • England
This amended and restated agreement is between Biomira International Inc., a Barbados corporation with offices located at Belleville, St. Michael, Barbados ("BIOMIRA"), and Merck KGaA, a German corporation with offices located at Darmstadt, Germany ("MERCK") and is effective as of March 1, 2006.
